ARCHIVES

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

This article is from The Cancer Letter archive.

Vol. 32 No. 39 | November 3, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

March 1, 2013

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

In Brief: DTP Combines Two Branches; Robert Cooper Names DCPC Board Chairman Weicker Receives MSK Award

June 28, 1985

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

Letter to the Editor: Expanding the Horizons Of Proton Beam Therapy

August 1, 2014